Enhanced restoration of visual code after targeting ON bipolar cells compared with retinal ganglion cells with optogenetic therapy
Molecular Therapy · 2025
DOI: 10.1016/j.ymthe.2025.01.030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2025. Verfasst von Jessica Rodgers und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biology, Medicine & Health, University of Manchester, Manchester M13 9PT, UK. Hauptthemen laut MEDLINE: Retinal Ganglion Cells, Optogenetics, Retinal Bipolar Cells, Retinal Degeneration. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, UK Research and Innovation Medical Research Council, Executive Unit for Financing Higher Education Research Development and Innovation.
Abstract (Originalsprache)
Optogenetic therapy is a promising vision restoration method where light-sensitive opsins are introduced to the surviving inner retina following photoreceptor degeneration. The cell type targeted for opsin expression will likely influence the quality of restored vision. However, a like-for-like preclinical comparison of visual responses evoked following equivalent opsin expression in the two major targets, ON bipolar (ON BCs) or retinal ganglion cells (RGCs), is absent. We address this deficit by comparing stimulus-response characteristics at single-unit resolution in the retina and dorsal lateral geniculate nucleus of retinally degenerate mice genetically engineered to express the opsin ReaChR in Grm6- or Brn3c-expressing cells (ON BC vs. RGCs, respectively). For both targeting strategies, we find ReaChR-evoked responses have equivalent sensitivity and can encode contrast across different background irradiances. Compared with ON BCs, targeting RGCs decreased response reproducibility and resulted in more stereotyped responses with reduced diversity in response polarity, contrast sensitivity, and temporal frequency tuning. Recording ReaChR-driven responses in visually intact retinas confirmed that RGC-targeted ReaChR expression disrupts visual feature selectivity of individual RGCs. Our data show that, while both approaches restore visual responses with impressive fidelity, ON BC targeting produces a richer visual code closer to that of wild-type mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Biology, Medicine & Health, University of Manchester, Manchester M13 9PT, UK.
- Nuffield Laboratory of Ophthalmology, Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX1 3QU, UK; Kavli Institute for Nanoscience Discovery, Unive…
- Nuffield Laboratory of Ophthalmology, Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX1 3QU, UK; Institute of Physiology and Pathophysiology, Dep…
- Neurogenetics Laboratory/ICDT, Transilvania University of Brasov, 500484 Brasov, Romania; National Brain Research Centre/ICIA, Romanian Academy, 050711 Bucharest, Romania.
- Faculty of Biology, Medicine & Health, University of Manchester, Manchester M13 9PT, UK. Electronic address: robert.lucas@manchester.ac.uk.
Förderung
- Wellcome Trust
- UK Research and Innovation Medical Research Council
- Executive Unit for Financing Higher Education Research Development and Innovation
- Pro Retina – Foundation for the Prevention of Blindness
- German Research Foundation
- Fight for Sight
- Royal Society
Zitieren
APA
Rodgers, J., Hughes, S., Ebrahimi, A. S., Allen, A. E., Storchi, R., Lindner, M., Peirson, S. N., Badea, T. C., Hankins, M. W., & Lucas, R. J. (2025). Enhanced restoration of visual code after targeting ON bipolar cells compared with retinal ganglion cells with optogenetic therapy. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2025.01.030
Vancouver
Rodgers J, Hughes S, Ebrahimi AS, Allen AE, Storchi R, Lindner M, et al. Enhanced restoration of visual code after targeting ON bipolar cells compared with retinal ganglion cells with optogenetic therapy. Molecular Therapy. 2025. doi:10.1016/j.ymthe.2025.01.030
BibTeX
@article{Rodgers2025,
author = {Rodgers, Jessica and Hughes, Steven and Ebrahimi, Aghileh S and Allen, Annette E and Storchi, Riccardo and Lindner, Moritz and Peirson, Stuart N and Badea, Tudor C and Hankins, Mark W and Lucas, Robert J},
title = {Enhanced restoration of visual code after targeting ON bipolar cells compared with retinal ganglion cells with optogenetic therapy},
journal = {Molecular Therapy},
year = {2025},
doi = {10.1016/j.ymthe.2025.01.030}
}
EUVIMED